Mankind Pharma Demonstrates Resilience Amid Broader Market Decline and Gains Momentum

Mankind Pharma has shown significant activity today, gaining 3.01% on July 14, 2025. The stock has outperformed its sector by 2.21%, marking a notable trend as it has experienced consecutive gains over the past five days, accumulating a total return of 9.01% during this period. The stock reached an intraday high of Rs 2655, reflecting a rise of 3.31%.
In terms of moving averages, Mankind Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong short-term performance relative to its historical trends.

In the broader market context, the Sensex opened flat but subsequently fell by 329.05 points, closing at 82,208.82, down 0.35%. Despite this decline, Mankind Pharma's performance stands out, particularly when compared to the Sensex's negative trajectory over the last three weeks, where it has lost 2.2%.

Over the past year, Mankind Pharma has delivered a return of 23.09%, significantly outperforming the Sensex, which has only seen a 2.11% increase. This performance highlights Mankind Pharma's resilience in a challenging market environment.